-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Company Profile
Mitsubishi Gas Chemical Co Inc – Company Profile
Mitsubishi Gas Chemical Co Inc (MGC) is a chemical company. It manufactures and sells basic chemicals, fine chemicals and functional materials. The company’s product portfolio includes petroleum-derived chemicals, chemical fertilizers, agricultural chemicals, feed additives synthetic resins and rubber, dyes, pigments, paints, adhesives pharmaceuticals, quasi-drugs, biochemical products, food and food additives detergents, bleaches, gas absorbers. MGC serves automobiles, environment, electronics, life sciences, and energy sectors in Asia, North America, and other regions. The company has manufacturing plants in Japan and R&D...
Add to Basket -
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Product Insights
Alzheimer’S Disease Disease – Global Clinical Trials Review, H2 2019
GlobalData's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H2, 2019" provides an overview of Alzheimer's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer's DiseaseReport includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...